Cytometry News and Research

RSS
Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

Study explores if prior exposure to common cold viruses may affect SARS-CoV-2 severity

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Novel label-free imaging method can differentiate active T cells from those off duty

Novel label-free imaging method can differentiate active T cells from those off duty

Study shows fused lung cells are pervasive in severe COVID-19

Study shows fused lung cells are pervasive in severe COVID-19

Researchers identify distinct immune profiles in COVID-19 patients

Researchers identify distinct immune profiles in COVID-19 patients

Antibodies to SARS-CoV-2 disappear within three months

Antibodies to SARS-CoV-2 disappear within three months

A tiny fish could end painful metabolic and genetic bone diseases

A tiny fish could end painful metabolic and genetic bone diseases

Novel antibody test for SARS-CoV-2

Novel antibody test for SARS-CoV-2

New technique reduces cell damage, improves IVF rates

New technique reduces cell damage, improves IVF rates

Important new findings on T cell immunity in COVID-19

Important new findings on T cell immunity in COVID-19

Irresistin: a ‘poison arrow’ to defeat antibiotic resistance

Irresistin: a ‘poison arrow’ to defeat antibiotic resistance

SARS-CoV-2 induces broad T cell response in recovering patients

SARS-CoV-2 induces broad T cell response in recovering patients

Promising candidate monoclonal antibodies show "exquisite potency" against SAR-CoV-2

Promising candidate monoclonal antibodies show "exquisite potency" against SAR-CoV-2

Mutational targets of SARS-CoV-2 receptor-binding domain for vaccine-antiviral development

Mutational targets of SARS-CoV-2 receptor-binding domain for vaccine-antiviral development

New range of SARS-CoV-2 Spike protein products

New range of SARS-CoV-2 Spike protein products

An entire trimeric S-protein of SARS-CoV-2 is necessary for protective immune response

An entire trimeric S-protein of SARS-CoV-2 is necessary for protective immune response

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Early neutralizing response to SARS-CoV-2 dominated by IgA antibodies

Study reveals novel mechanism that triggers a cell-mediated immune response

Study reveals novel mechanism that triggers a cell-mediated immune response

Females mount stronger T-cell response to SARS-CoV-2

Females mount stronger T-cell response to SARS-CoV-2

Study investigates potential of adoptive cell therapy in combination with checkpoint inhibitors

Study investigates potential of adoptive cell therapy in combination with checkpoint inhibitors